Efficacy and Safety of Estracyt® in Metastatic Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Estramustine|DRUG: standard practice
Sponsor: Centre Hospitalier Universitaire de Besancon